Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HW Nanomaterials, officially known as Guangzhou Hongwu Material Technology Co., Ltd., is a leading manufacturer and supplier of high-quality nanomaterials for the life sciences, healthcare, and industrial sectors. Founded in 2002 and headquartered in Guangzhou, China, the company specializes in the research, development, and large-scale production of metal nanoparticles, carbon nanotubes, and oxide nanopowders. Their products are integral to the development of antibacterial coatings, advanced medical imaging contrast agents, and targeted drug delivery systems. HW Nanomaterials operates a sophisticated synthesis platform that bridges laboratory-scale innovation with industrial demand. The company serves a global client base, providing essential materials that drive advancements in nanomedicine and biotechnology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HW Nanomaterials.